Cannabis Bioscience International Holdings (CBIH) Operating Expenses (2022 - 2025)
Historic Operating Expenses for Cannabis Bioscience International Holdings (CBIH) over the last 7 years, with Q3 2025 value amounting to $90841.0.
- Cannabis Bioscience International Holdings' Operating Expenses fell 6612.04% to $90841.0 in Q3 2025 from the same period last year, while for Aug 2025 it was $506993.0, marking a year-over-year decrease of 2668.09%. This contributed to the annual value of $684281.0 for FY2025, which is 73.99% down from last year.
- As of Q3 2025, Cannabis Bioscience International Holdings' Operating Expenses stood at $90841.0, which was down 6612.04% from $165311.0 recorded in Q2 2025.
- Over the past 5 years, Cannabis Bioscience International Holdings' Operating Expenses peaked at $311998.0 during Q1 2023, and registered a low of $90841.0 during Q3 2025.
- Its 4-year average for Operating Expenses is $192972.2, with a median of $174942.0 in 2024.
- Its Operating Expenses has fluctuated over the past 5 years, first tumbled by 6868.09% in 2024, then surged by 7288.69% in 2025.
- Quarter analysis of 4 years shows Cannabis Bioscience International Holdings' Operating Expenses stood at $259099.0 in 2022, then tumbled by 44.74% to $143168.0 in 2023, then fell by 11.94% to $126072.0 in 2024, then fell by 27.95% to $90841.0 in 2025.
- Its Operating Expenses stands at $90841.0 for Q3 2025, versus $165311.0 for Q2 2025 and $124769.0 for Q1 2025.